IFF FOURTH QUARTER & FULL YEAR 2022 EARNINGS CONFERENCE CALL

Pricing Actions -Achieved >$1B in price increases to recover total inflation.

Nourish: Profitability driven by strong price increases and productivity.

Health &
Biosciences: Price increases and productivity offset by lower volumes.

Comparable currency neutral adjusted operating
EBITDA1 2 declined 5% as strong pricing and productivity
gains were more than offset by lower volumes.

OUTLOOK: Inflationary trend continues – with greater volatility – as costs remain
at elevated levels; Targeting to fully cover dollar cost via pricing

OPERATING PRIORITIES: Accelerate volume growth, targeted investments &
successful pricing execution to offset inflation